No phaseCompletedHealthspan endpoint

Melatonin Supplementation and Exercise Program in Breast Cancer Women (MEXBSO)

Impact of Melatonin Supplementation Plus Exercise Program in Women Who Have Suffered From Breast Cancer in the Province of Soria, Spain

Sponsor
University of Valladolid (Academic or other)
Enrollment
42 enrolled
Conditions
Female Breast Cancer; Older Adults; Exercise Trainning Progrmam
Interventions
Melatonin 6 mg; Placebo
Ages
adults, older adults
Registry
NCT06696378

Full record on ClinicalTrials.gov

From the registry

Introduction: Breast cancer (BC) remains the leading cause of cancer in women with nearly 1.4 million new cases worldwide annually and 27.000 in Spain. Increasingly effective oncology therapies, however, have numerous adverse effects such as muscle degeneration, fatigue, decreased physical function and aerobic capacity, and deteriorating quality of life. In this sense, physical activity (PA) seems to be an interesting non-pharmacological strategy to alleviate these serious complications and with potential benefits for women with BC. Melatonin (N-acetyl-5 methoxytryptamine) is an indolic compound present with pleiotropic bioactions that regulates the circadian rhythm, antioxidant, anti-inflammatory, immunostimulant, cardioprotective, antidiabetic, antiobesity, neuroprotective, and antiaging actions. Furthermore, in recent years, many studies have described the key role of melatonin in preventing and developing cancer. The general anticarcinogenic mechanisms include epigenetic control, cell proliferation modulation, cell cycle regulation, apoptosis induction, and telomerase…

Primary outcomes

  • Plasma irisin concentration
  • Plasma sestrin-2 concentration

History

  1. Last registry update

  2. Primary completion

  3. Registered

  4. Started

Papers citing this trial